Physician profile

N Hennessey

New York, NY

NPI 1285694661

$1,217.83

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$169.39

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Leo Pharma As $450.00 2022
Abbvie INC. $203.59 2020-2024
Janssen Biotech, INC. $190.33 2019-2022
Dermavant Sciences, INC. $117.42 2023 Vtama
Genentech USA, INC. $85.08 2019-2020
Leo Pharma INC. $58.41 2019-2021
Celgene Corporation $32.48 2019
Sun Pharmaceutical Industries INC. $29.57 2020-2021
Biofrontera INC. $23.36 2019
Arcutis Biotherapeutics, INC. $15.57 2023
Pfizer INC. $12.02 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

N Hennessey

$1,217.83

in general payments reported 2019-2025

Years
2019-2024
Top company
Leo Pharma As

https://glasscript.com/doctor/240121/n-hennessey

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.